fy19 3rd quarter financial results - hitachi...2020/01/29  · ebit : 48.5 ybn (yoy:- 1.1 ybn)...

18
Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. FY19 3rd Quarter Financial Results January 29, 2020 Shinji Sakurai Vice President and Executive Officer Hitachi High-Technologies Corporation

Upload: others

Post on 27-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved.

FY19 3rd Quarter Financial Results

January 29, 2020Shinji Sakurai Vice President and Executive OfficerHitachi High-Technologies Corporation

Page 2: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 2

3. Reference

FY19 3rd Quarter Financial Results

1. Outline of FY19 Q1-Q3 (Highlights)

2. FY19 Outlook

Contents

Page 3: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 3

FY19 Q1-Q3 ResultsRevenues : 517.0 Ybn (YoY:-4%)EBIT : 48.5 Ybn (YoY:-1.1 Ybn)

Results by Segment (YoY): Revenues and profits decreased Analytical & Medical Solutions

Nano-Technology SolutionsIndustrial Solutions

: Revenues and profits increased : Revenues and profits decreased

Outline of FY19 Q1-Q3 (Summary)

Page 4: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 4

1. Outline of FY19 Q1-Q3 (Highlights)

Page 5: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved.

FY19 1-3QResults

FY18 1-3QResults YoY

Revenues 5,170 5,405 -235(-4%)

Adjusted OperatingIncome*1 482 514 -33(-6%)

EBIT*2 485 496 -11(-2%)

Income before Income Taxes 488 500 -12(-2%)

Net Income*3 366 364 +2(+1%)

Net Incomeper Share 265.98 yen 264.65 yen +1.33 yen

5

(100 million yen)

・Exchange rate : 1USD=109 yen, 1EUR=121 yen*1 Adjusted operating income is presented as revenues less cost of sales as well as selling, general and administrative expenses*2 EBIT(Earnings Before Interest and Taxes) is presented as income before income taxes less interest income and interest expenses *3 Net Income is presented as net income attributable to Hitachi High-Technologies Corporation stockholders

Outline of FY19 Q1-Q3 (Highlights)

Page 6: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 6

FY19 Q1-Q3Results

Explanation of DeviationsRevenues EBIT

1,192(-2%)

197(-15)

Revenue and EBIT decreased due to the impact of change inforeign exchange rates and selling price in clinical analyzers.

1,536(+11%)

313(+36)

Revenue and EBIT increased due to the strong sales to Logic and Foundries customers investing in mass production and next-generation cutting-edge processes.

2,487(-13%)

1(-42)

Revenue and EBIT decreased due to the decline in large ordersfor liquid crystal display exposure systems, the partial endingof automotive parts transactions, the decreased demand anddrop in price of manufacturing components and additionalcosts for part of large orders.

Total 5,170(-4%)

485(-11)

Analytical & Medical Solutions

Nano-Technology Solutions

Industrial Solutions

Outline of FY19 Q1-Q3 (Explanation of Deviations)

(100 million yen)

Note: ・YoY are compared with restated figures of FY18 1H・Elimination such as subtractions in intersegment transactions, etc., are included in the total

( ) : YoY

Page 7: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 7

2. FY19 Outlook

Page 8: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved.

FY19 Outlook(Jan. 2020 ) FY18 Results YoY

vs. Previous Forecast

(Oct. 2019)

Revenues 7,000 7,311 -311(-4%) ±0(±0%)

Adjusted Operating Income*¹ 560 667 -107(-16%) ±0(±0%)

EBIT*² 600 642 -42(-7%) ±0(±0%)

Income before Income Taxes 600 648 -48(-7%) ±0(±0%)

Net Income*³ 440 484 -44(-9%) ±0(±0%)

Net Incomeper Share 319.94 yen 352.06 yen -32.12 yen ±0.00 yen

8

(100 million yen)

・Exchange rate : 1USD=105 yen, 1EUR=120 yen*1 Adjusted operating income is presented as revenues less cost of sales as well as selling, general and administrative expenses*2 EBIT(Earnings Before Interest and Taxes) is presented as income before income taxes less interest income and interest expenses *3 Net Income is presented as net income attributable to Hitachi High-Technologies Corporation stockholders

FY19 Outlook (Highlights : Earning Forecast)

Page 9: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved.

FY19 Outlook(Jan. 2020 ) FY18 Results YoY

vs. Previous Forecast

(Oct. 2019)

ROE 10.1% 11.9% -1.8% ±0%

ROA* 6.3% 7.3% -1.1% ±0%

FCF 31.8 Ybn 12.1 Ybn +19.7 Ybn +11.8 Ybn

Cash Dividendper Share

115.00 yen 105.00 yen +10.00 yen ±0.00 yen

9

*ROA(Return On Assets) : Net income before deducting non-controlling interests / total assets (end of the fiscal year) x 100

FY19 Outlook (Highlights : Management Indicators)

Page 10: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 10

FY19 Outlook(Jan. 2020) FY18 Results YoY

vs. Previous Forecast

(Oct. 2019)

Revenues EBIT Revenues EBIT Revenues EBIT Revenues EBIT

1,659 256 1,664 286 -0% -30 ±0% +10

2,165 394 1,871 347 +16% +47 +2% +39

3,334 1 3,865 64 -14% -63 +0% -22

Total 7,000 600 7,311 642 -4% -42 ±0% ±0

Analytical & Medical Solutions

Nano-Technology Solutions

Industrial Solutions

Note: ・ FY18 figures are restated・Elimination such as subtractions in intersegment transactions, etc., are included in the total

(100 million yen)

FY19 Outlook (Revenue and EBIT by Segment)

Page 11: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved.

1,388 1,371 1,379

277 288 280

0

1,000

2,000

FY19 Outlook (Analytical & Medical Solutions)

11

Revenues / EBIT Trend

+1%

Bio & MedicalSystems

-3%

Analytical Systems

1,664 1,659

EBIT 286 246 256

1,659 ±0%

Revenues

Bio & Medical Systems Demand for clinical analyzers continues to grow steadily

Analytical Systems

・Demand in food, environment, and new energy fields remain steady・Demand in fields such as electronic components, etc., is also expected to increase

Revenuesvs. Previous Forecast(Oct.2019)

(100 million yen)

*FY18 figures are restatedFY19

Outlook(Jan. 2020)

FY19Outlook

(Oct. 2019)

FY18Results

Page 12: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved.

686 908 930

1,179 1,217 1,231

0

1,200

2,400

12

+1%

Metrology& Analysis Systems

+2%

Process systems

1,8712,129 2,165

Revenues / EBIT Trend

EBIT 347 355 394

Revenues

+2%

Process systems Investments in cutting-edge processes from Logic and Foundries customers remain strong

Metrology& Analysis Systems

Metrology Investments from some Memory customers have resumed

Analysis・Strong sales of electron microscopes to continue, mainly for Europe and the US market・Demand for the development of electronic materials, and for the

semiconductor analysis field, are also expected to increase

FY19 Outlook (Nano-Technology Solutions)

(100 million yen)

FY19Outlook

(Jan. 2020)

FY19Outlook

(Oct. 2019)

FY18Results *FY18 figures are restated

Revenuesvs. Previous Forecast(Oct.2019)

Page 13: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved.

1,370 1,260 1,260

856 593 601

1,638 1,477 1,473

0

2,000

4,000

13

3,865

Materials, Fuel, Chemicals & Others

Social & Industrial Infrastructure

Automobiles& Mobility

3,329

Revenues / EBIT Trend

EBIT 64 23 1

+0%

Revenues

-0%

+1%

±0%

3,334

Although demand for automation and productivity improvements remains solid,there are uncertainty around when investment will be made, decreasing demand, price fluctuations for materials and automotive components

FY19 Outlook (Industrial Solutions)

(100 million yen)

FY19Outlook

(Jan. 2020)

FY19Outlook

(Oct. 2019)

FY18Results *FY18 figures are restated

Revenuesvs. Previous Forecast(Oct.2019)

Page 14: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 14

3. Reference

Page 15: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 15

Changes in Orders Received (Results)

138 166329 341

102237 270

196 101

184 217

203

257 219334267 306

0

300

600

1Q 2Q 3Q 4Q 1Q 2Q 3Q

0% 50% 100%

3Q

2Q

20/3 1Q

19/3 4Q DRAM

NAND

Logic

MPU

Foundry

Others

FY18 FY19

512

18% 22% 40% 9%11%

19% 52%9 %

8% 1% 11%

558494

14% 15%18% 49%4 %

489

6% 21%10% 56%7 %

Reference of Nano-Technology Solutions

(100 million yen)

■Metrology & Analysis Systems(Except for Electron Microscopes related)

■Process System

*Based on unit sales,Except for Electron Microscopes relatedFront End Equip. Revenues Ratio by Fields (Results)

FY18

FY19

Page 16: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 16

Changes in Quarterly Results

FY18 FY19

1Q 2Q 3Q 4Q 1Q 2Q 3Q

Revenues/

EBIT

Analytical & Medical Solutions

Revenues 409 405 397 454 398 396 399

EBIT 80 58 74 74 64 53 80

Nano-Technology Solutions

Revenues 421 551 417 482 455 552 528

EBIT 80 123 75 69 92 116 105

Industrial SolutionsRevenues 919 966 982 998 774 915 798

EBIT 12 13 18 21 -5 6 0

Others & Elimination/Corporate

Revenues -19 -20 -22 -28 -11 -15 -19

EBIT -12 -14 -11 -18 -6 -11 -8

TotalRevenues 1,730 1,901 1,774 1,906 1,616 1,848 1,706

EBIT 160 180 156 146 144 163 177

Income before Income Taxes 161 181 158 148 145 165 178

Net Income Attributable to Hitachi High-Technologies Corporation Stockholders

106 140 118 120 98 128 140

*FY18 figures are restated

(100 million yen)

Page 17: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 17

Revenues Change in Main Business

FY18 FY19

1Q 2Q 3Q 4Q 1Q 2Q 3Q

Analytical & Medical Solutions 409 405 397 454 398 396 399

Bio & Medical Systems 349 333 331 373 341 321 337

Analytical Systems 60 71 65 81 56 74 62

Nano-Technology Solutions 421 551 417 482 455 552 528

Process Systems 175 172 142 197 204 252 263

Metrology & Analysis Systems 245 377 274 284 250 299 264

Others 1 1 1 1 1 1 1

Industrial Solutions 919 966 982 998 774 915 798

Social & IndustrialI nfrastructure 303 363 331 374 254 398 286

Automobiles & Mobility 205 201 224 227 145 148 141

Materials, Fuel, Chemicals & Others 411 402 428 398 375 368 371*FY18 figures are restated

(100 million yen)

Page 18: FY19 3rd Quarter Financial Results - Hitachi...2020/01/29  · EBIT : 48.5 Ybn (YoY:- 1.1 Ybn) Results by Segment (YoY) Analytical & Medical Solutions : Revenues and profits decreased

Copyright ©2020 Hitachi High-Technologies Corporation All Rights Reserved. 18

FY19 3rd Quarter Financial Results

For further informationMitsuru KuwabaraGeneral Manager, CSR & Corporate Communications Dept.,CSR Div.TEL:+81-3-3504-7111 FAX:+81-3-3504-5943E-mail:[email protected]

Notes on the data1. All financial statement summaries and results predictions included in this presentation are on a consolidated basis unless otherwise stated.

Numerical data is rounded off to the nearest 100 million yen.2. In its disclosures, Hitachi High-Technologies may make statements that constitute forward-looking statements that reflect management‘s views with

respect to certain future events and financial performance at the time of disclosure. Such statements are based on information available at the timeof disclosure and may differ from actual results due to various external factors, both direct and indirect. In the event of a major discrepancy with theitems disclosed, the Company will disclose on a case-by-case basis based on the law and/or the timely disclosure rules and regulations of the stockexchanges on which the Company is listed.

The information included in this material is for reference when investing, and not a canvass to invest. Brand selection and the final decision is at yourown judgment.